These prestigious honors will be presented at AMP 2025 in Boston.
Elaine R. Mardis, Ph.D., will give a keynote lecture at AMP 2025 titled "The Advancement of Next-Generation Sequencing and Analytics for Pediatric Precision Diagnosis."
Elaine Mardis will receive AMP’s highest honor for her groundbreaking work in cancer genomics, immunogenomics and analytics, as well as for her significant contributions to advancing molecular diagnostics.
She will give a keynote lecture titled "The Advancement of Next-Generation Sequencing and Analytics for Pediatric Precision Diagnosis."
An internationally recognized expert with more than 550 published manuscripts, she co-led the effort to sequence and analyze the first cancer genome using massively parallel sequencing and played a key role in major cancer genomics initiatives including The Cancer Genome Atlas and the Pediatric Cancer Genome Project.
Her research focuses on clinical profiling of pediatric cancer to identify somatic and germline drivers of disease and characterize the tumor immune microenvironment.
Alexis B. Carter, M.D.
Alexis Carter will be recognized for her leadership in molecular pathology and her dedication to advancing the field through innovation and mentorship.
An active AMP member for more than 20 years, Carter has held several leadership roles, including chair of the Informatics Subdivision (2014–2018), chair of the Finance Committee (2021–2023) and chair of the EHR Interoperability for Clinical Genomics Working Group (2020–2025). She was AMP's secretary–treasurer from 2021 to 2023.
Carter previously received AMP’s Meritorious Service Award in 2017.
She is a former fellow of Jeffrey Kant, for whom the award is named. Kant played a pivotal role in establishing AMP and served as its first president. He received the inaugural AMP Leadership Award in 2005.
Dara L. Aisner, M.D. Ph.D.
Dara Aisner will be honored for her unwavering advocacy for precision medicine and her influential work in developing molecular laboratory procedures.
Her past service to AMP includes participation in numerous committees and working groups, such as the Training and Education Committee (2010), the Molecular Curriculum Task Force (2011–2014) and the Economic Affairs Committee (2012–2018).
She currently serves on the U.S. Food and Drug Administration Rulemaking Task Force.
In 2024, she testified before the House Committee on Energy and Commerce on FDA regulation of laboratory-developed tests, reflecting her commitment to policy and practice at the national level.
Lawrence J. Jennings, M.D., Ph.D.
Lawrence Jennings will be recognized for his longstanding service to AMP and his many contributions to molecular diagnostics.
Over the past decade, he has participated in 10 AMP workgroups and has chaired both the Next-Generation Sequencing Assay Validation Workgroup and the Solid Tumor Subdivision.
He has played a key role in developing professional standards through work with a variety of associations responsible for issuing clinical guidelines. His publications on assay validation and implementation have helped to shape clinical laboratory practices worldwide.
A frequent and engaged contributor at AMP meetings, Jennings exemplifies AMP’s mission through collaboration and leadership.
.png)
AMP is pleased to offer a number of prestigious awards for outstanding work in the field of molecular diagnostics. These awards are designed to assist, support and honor members of the molecular diagnostics community.
Applications open: April 1, 2025
Application deadline: June 30, 2025
AMP offers recognition awards, membership grants and travel awards for meetings held outside of the U.S.